Clinical Trial Results: A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atezolizumab and bevacizumab in unresectable hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Howard S Hochster | Conditions: Unresectable Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-06-16